A consortium of the five University of California medical campuses – Davis, Irvine, Los Angeles, San Diego and San Francisco – has been awarded a $12 million grant and designated by the National Institutes of Health (NIH) as one of three Centers for Accelerated Innovations by the National Heart, Lung and Blood Institute (NHLBI).
The designation, among the first of its kind from NHLBI, recognizes the University of California’s potential to translate its leading-edge discoveries into innovative products that benefit patients.
The University of California Center for Accelerated Innovation (UC CAI) will leverage the expertise and resources of the five state medical campuses and use industrial product-development practices to incubate technologies with high commercial potential. The five campuses accounted for 7 percent of NHLBI’s fiscal year 2012 grant funding, providing a rich research base to support a diverse pipeline of diagnostics, devices, therapeutics and tools for heart, lung and blood diseases.
Read more at UCSF.edu